Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regenerative Medical Technology (RMTG) Cash & Current Investments (2017 - 2025)

Historic Cash & Current Investments for Regenerative Medical Technology (RMTG) over the last 9 years, with Q3 2025 value amounting to $1.2 million.

  • Regenerative Medical Technology's Cash & Current Investments rose 4175.71% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 4175.71%. This contributed to the annual value of $1.2 million for FY2024, which is 11974.21% up from last year.
  • According to the latest figures from Q3 2025, Regenerative Medical Technology's Cash & Current Investments is $1.2 million, which was up 4175.71% from $1.6 million recorded in Q2 2025.
  • Over the past 5 years, Regenerative Medical Technology's Cash & Current Investments peaked at $18.9 million during Q3 2021, and registered a low of $530540.0 during Q4 2023.
  • In the last 5 years, Regenerative Medical Technology's Cash & Current Investments had a median value of $1.2 million in 2023 and averaged $2.8 million.
  • In the last 5 years, Regenerative Medical Technology's Cash & Current Investments skyrocketed by 9060242.03% in 2021 and then tumbled by 9065.11% in 2022.
  • Over the past 5 years, Regenerative Medical Technology's Cash & Current Investments (Quarter) stood at $3.0 million in 2021, then plummeted by 44.77% to $1.6 million in 2022, then crashed by 67.75% to $530540.0 in 2023, then surged by 119.74% to $1.2 million in 2024, then rose by 1.7% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, $1.6 million for Q2 2025, and $1.2 million during Q1 2025.